Cites
VC Fund
Sunchales, Argentina
Cites is a VC fund in Sunchales focused on Medical and Biotechnology. Cites Startups 2014 Center for Technological Innovation and Social Enterprise, a startup Sancor Insurance Group created to support innovation. They want to generate a cluster of technology companies and exercise role linker between research sectors, production, business and social. They do this by providing an interdisciplinary support betweentechnology and business, with the aim of strengthening the scientific, economic and social development of the region and country areas.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Cites invests in
Stages Cites invests in
Countries Cites invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Nicolas Tognalli
|
|||
Ezequiel Manavela Chiapero
|
|||
Gerardo R. Marchesini
|
|||
Investment Focus
Industry
- Medical 4 (44%)
- Biotechnology 4 (44%)
- Medical Device 4 (44%)
- Health Care 3 (33%)
- Software 2 (22%)
Stage
- Seed 8 (89%)
- Series A 1 (11%)
Country
- Argentina 5 (56%)
- United States 4 (44%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Nicolas Tognalli
Managing Partner
|
Managing Partner | Total investments: 1 | Find email | |
|
Ezequiel Manavela Chiapero
Chief Technology Business Developer
|
Chief Technology Business Developer | Total investments: 0 | Find email | |
|
Gerardo R. Marchesini
Chief Scientific Business Developer and General Partner
|
Chief Scientific Business Developer and General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Teramot
|
Teramot’s AI software helps companies access data quickly and easily, improving decision-making with less effort. | Seed / Jan 01, 2024 | |
NeuroAcoustics
|
NeuroAcoustics helps treat neurological conditions by managing brain waves during sleep with personalized, simple devices. | Seed / Jan 01, 2024 | |
Selectivity Life
|
Selectivity Life is a healthcare company which develops reproductive medical devices which bring fertility treatments to patients' homes. | $180K / Seed / Jan 01, 2023 | |
Epiliquid
|
Epiliquid develops a platform for early cancer detection using specific biomarkers through liquid biopsies. | Seed / Jan 01, 2023 | |
Limay Biosciences
|
We use innovative biotechnologies to develop fast, simple and accessible molecular testing solutions. | $600K / Seed / Aug 12, 2022 | |
CRINSURANCE
|
CRINSURANCE offers a cryotank that preserves embryos safely and tracks them digitally, saving time for IVF labs. | Seed / Jan 01, 2021 | |
Stradot
|
Stradot creates high-speed, eco-friendly parking systems that save space and cut costs in crowded urban areas. | Seed / Jan 01, 2021 | |
Viewmind
|
ViewMind is a digital health and artificial intelligence company. It analyzes eye movement patterns using its AI-powered comprehensive neurocognitive health assessments. To detect and track Alzheimer's disease and other neurocognitive problems, ViewMind uses eye movement monitoring to acquire the most accurate type of brain health data. | $1M / Seed / Sep 01, 2020 | |
Eolo Pharma
|
Pharma develops molecular drugs intended to cure chronic inflammation. It specializes in the research and development of medicines that target the molecular and cellular basis of inflammation-related diseases. | $2.7M / Series A / Jan 07, 2020 |
Co-Investors
Agencia Córdoba Innovar y Emprender
1 deal together
SF500
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cites invest in?
Cites invests primarily in Medical, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Argentina. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cites?
Public channels for Cites include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cites?
The team at Cites includes Nicolas Tognalli (Managing Partner), Ezequiel Manavela Chiapero (Chief Technology Business Developer) and Gerardo R. Marchesini (Chief Scientific Business Developer and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
